SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Healthcare >

AVVAA World Health Care Products (AVVH)

AVVH RSS Feed
Add AVVH Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 10/26/2017 11:48:01 PM - Followers: 87 - Board type: Free - Posts Today: 0

avVaa World Health Care Products

 


New Website for Neuroskin products: http://www.neuroskin.com/

Visit Neuroskin on FACEBOOK

AVVH is fully compliant and up to date with the SEC.                                                               >>>   685,024,000  Restricted shares plus the BCSC CTO in Canada have half the float tied up.   <<<


RECENT NEWS HEADLINES :

2014/05/16  http://www.marketwatch.com/story/resignation-of-AVVH director-and-officer-Jason Price

2014/03/28 Avvaa anounces the addition of 2 new products to its Neuroskin brand


2014-03-18  Consolidated Financial Statement   >>>>>SALES UP OVER 600 %<<<<<

2014/11/18  Marketwatch.com- Walgreens distribution agreement

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=111888   2013/10/14  Interim Financial Report (>>>>>sales UP<<<<<)

https://www.otciq.com/otciq/ajax/showFinancialReportById.pdf?id=111822   2013/10/09  Supplemental Information concerning Annual OTC Disclosure
 
http://finance.yahoo.com/news/avvaa-signs-distribution-agreement-natural-130000479.html 2013/10/21 NEUROSKIN products now carried byVP Plus Marketing


http://www.otcmarkets.com/stock/AVVH/news?id=69674  2013/10/10 AVVAA Files Form with BCSC to Cease Being a Reporting Company in British Columbia in order to have BCSC CTO removed

http://www2.thestockmarketwatch.com/newsletters-2013/09/17 NEUROSKIN products offered on Yeswellness.com

http://online.wsj.com/article/PR-CO-20130819-908249.html  Interview with the new CEO Jason Price

http://finance.yahoo.com/news/avvaa-world-health-care-products-154500189.html
  2013/08/12 AVVH successfully negotiates the rights to the trademark 'Neuroskin'

http://www.marketwatch.com/story/avvaa-world-health-care-products-announces-major-sales-contracts-2013-08-05 Sales contract with Petonic Pet Supply and Atlantic Co-Op Country store chain

http://www.marketwatch.com/story/avvaa-updates-financials-promoted-to-otc-pink-current-information-2013-05-01 AVVH promoted to OTC current status


Chairman & CEO:                                                          Transfer Agent:
  Jason S. Price                                                              Signature Stock Transfer Company,
  P: 1-866-864-6598                                                         2632 Coachlight Court Plano TX 75093
  Email: jason.price@avvaa.com                                        Telephone: 972.612.4120

Corporate Office:                                                           A/S: 4,000,000,000
7400 Beaufont Springs Dr.                                                  O/S: 1,882,828,559  7/29/2013                                        
Suite 300                                                                           
Richmond, VA. 23225                                                          At least 685,024,000 of the O/S are restricted by SEC rule 144 http://www.mofo.com/files/Uploads/Documents/FAQRule144_145.pdf
Telephone: 1.866.864.6598                                                                             plus there is currently a CTO for Canadian shareholders
 


About avVaa World Health Care Products


avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that

improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and

were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is

marketing it's Neuroskin line of skin care products through mass food and drug channels such as Walgreens in the United States and globally. The Company's

secondary line of equine and pet care related products are already being distributed by the Atlantic Co-Op Country Store chain throughout all of Canada. For more information, visit: www.neuroskin.com




About the NEUROSKIN®  line of skin care products:

For online purchases, go to http://www.neuroskin.com/

NEUROSKIN offers products for psoriasis relief, mild skin conditions, acne treatment and itch relief. Neuroskin products are tested and FDA compliant and DIN approved as over-the-counter pharmaceuticals as well as cosmetic skin care products. They are available over-the-counter and are extremely easy to use, non-toxic products, having no side effects on the human body or the environment. The products do not contain unnatural ingredients such as cortisone, antibiotics and alcohol. The formula is non-greasy, odorless and does not stain clothing, unlike other creams and ointments. Patients have reported noticeable reduction of symptoms after just the first application. NEUROSKIN will replace prescription medication for patients, using expensive therapies and steroids. NEUROSKIN fits with the attitude of the century, which is to go more natural and avoid potentially toxic substances.

There is presently no cure for psoriasis and eczema, skin diseases which are chronic and require continuous therapy. Patients are required to seek out products that can relieve and treat the symptoms of itching and redness caused by these skin irritations. Tests in Germany have proven the product to be effective on 995 out of 1000 people (99.5%). The tests indicated and proved NEUROSKIN did not cause any side effects. Unlike many competitors, NEUROSKIN does not contain cortisone, antibiotics, alcohol, steroids or other unnatural ingredients or additives. The formula is non-greasy and odorless, does not stain clothing, and is easy to use.

NEUROSKIN Psoriasis Relief is a patented, steroid-free, all natural therapeutic skin care product containing minerals and oils in a non-greasy fast drying formula that cools and sooths irritated skin. The product reduces inflammation, redness and itching and it promotes healing and repair of damaged skin, enhancing its natural texture. NEUROSKIN Psoriasis Relief treats the symptoms of psoriasis as well as eczema, dermatitis and other minor skin irritations. This product is FDA-compliant and DIN approved as an over-the-counter OTC product. avVaa owns the blow-molds for the unique 50 ml bottle which was developed using focus groups from the medical fields.

NEUROSKIN Mild Skin Moisturizer is a natural cosmetic for those with sensitive skin (elderly and babies) NEUROSKIN Mild Skin Moisturizer has had early success in the treatment of radiation and thermal burns. Dr. Alden will be working closely with this product in clinical trials for the specific treatment of burns.

NEUROSKIN Acne Treatment is a cosmetic skin care product, which clears up acne, promoting blood circulation on the affected parts of the skin. Within a few days the inflamed "blackhead" pores open, their contents expel, and then proceed to dry up. This product is FDA-compliant and DIN approved as and over-the-counter OTC product.

NEUROSKIN Itch Relief is a steroid-free, all natural topical analgesic lotion, which relieves the discomfort and stops the itch caused by insect bites, allergies, shingles, minor cuts and other minor skin irritations. This product is FDA-compliant and DIN approved as an over-the-counter OTC product.
 

Disease Descriptions

Psoriasis is a chronic skin disease marked by periodic flare-ups of sharply defined red patches covered by a silvery, flaky surface.

Eczema (atopic dermatitis) is an allergic skin condition that causes itching, sometimes to an intense degree. Over time, the lesions tend to scale and flake. If bacterial or viral infection is introduced by scratching, the affected lesions will ooze.

Acne is a disorder of the skin's oil glands that results in plugged pores and outbreaks of lesions commonly called pimples or zits. Acne lesions usually occur on the face, neck, back, chest and shoulders.

With the successful transfer of FDA, DIN numbers and label parameters from the Inventor to avVaa World Health Care Products, avVaa now owns the exclusive right to manufacture, market, label, distribute and sell its line of proven skin care products throughout the United States and Canada. avVaa products included in the FDA and DIN transfers are: NEUROSKIN Acne Treatment, an acne medication lotion; NEUROSKIN Psoriasis Relief, for seborrheic dermatitis and psoriasis lotion; and NEUROSKIN Itch Relief, a topical analgesic lotion.

For online purchases, go to http://www.neuroskin.com/

  • Rapid Revenue Results. According to Management, the Company's product, NEUROSKIN® Psoriasis Relief has the potential to bring in revenues of over $6.7 Million, with potential projected sales of over $12.7 Million over a 12 month period.
  • Natural & Environmentally Friendly Products. Recent headlines focusing on tests done on two substances, known as D4 and D5, which is found in shampoo, soap, antiperspirant and hundreds of other personal care products, showed they pose a danger to wildlife and aquatic life. There are hundreds of thousands of beauty care products available around the world, most containing damaging chemicals, preservatives and toxins. None of avVaa World Health Care products do not contain the 2 chemicals, known as cycolmethicone exact D4 and D5. The products are all effective, natural, therapeutic skin care products for humans and animals alike.
  • Superior Lead Product. Tests in Germany have proven that the NEUROSKIN product to be effective on 995 out of 1000 people (99.5%). The tests indicated and proved NEUROSKIN did not cause any side effects. Unlike many competitors, NEUROSKIN does not contain cortisone, antibiotics, alcohol, steroids or other unnatural ingredients or additives. The formula is non-greasy and odorless, does not stain clothing, and is easy to use.
  • Huge Market Potential. The United States alone has an estimated market size of 40 million skin disease sufferers and a potential market spending of US $4 Billion. There are 7 million people living in the United States that are affected by some form of psoriasis. Approximately two hundred and fifty thousand new cases are reported each year.
  • Seasoned Management Team. The management team of avVaa World Health Care Products is strong in the sales and marketing with strong emphasis in financial accounting, pharmaceutical and banking experience. The medical research team is comprised of world-renowned medical professionals in the fields of dermatology and radiation oncology.
     

  Market Potential

  • Seventeen million (17 million) Americans have acne (*The National Institute of Arthritis and Musculoskeletal and Skin Diseases).
  • There are 7 million people living in the United States that are affected by some form of psoriasis. Approximately two hundred and fifty thousand new cases are reported each year. (*Well-Connected Report, 1999 Nidus Information Services Inc., June 1999).
  • "Skin problems are exceedingly common: 30% of Americans have dermatological conditions requiring a physician's care. Moreover, the skin and its appendages (the hair and nails) play a paramount role in our psychological makeup." (*Cecil Textbook of Medicine 20th edition, 1996).
  • Over 16 million people living in the United States are affected by eczema (*The National Institute of Arthritis and Musculoskeletal and Skin Diseases).
  • *Research by the National Psoriasis Association, the USA Dermatologist Association and other institutions indicate that close to $4 billion is spent on treatments for psoriasis, eczema, and acne per year.
  • "85% of the US population between ages 12-25 develops some form of acne." (*FDA Consumer Report, "On the Teen Scene" section of WebMD Health).
  • The psoriasis market is continuing to grow with the aging population and affects between 0.5% - 3% of the world's population, (*Well-Connected Report, 1999 Nidus Information Services Inc., June 1999).
  • *Forrester Research states in their article "B2B Healthcare Spending Shifting Online" (Jan. 2000), "Over-the-counter drugs, health and beauty aids will contribute $1.9 billion and $900 million, respectively, to the online retail category."
  • The market size for the health and natural food store market tops 9,245 stores in USA with sales reaching $14 billion in 2000. (*source: www.marketresearch.com)

 

Target Markets

Primary Target Markets

  • Individuals suffering with psoriasis, eczema and acne and various other skin diseases;
  • Pharmaceutical Retail outlets;
  • Mainstream and Specialty Drug and Food Chain outlets
  • Institutions - hospitals, clinics, prisons.

Secondary Target Markets

  • Health and Natural Food Store Market.
  • Private brand companies.

The initial focus has been directed on the primary US and Canadian target markets. Entry into Central America, South America and eventual world markets will be next. Distribution and sales agreements have been discussed with several countries to date.

Private branding allows skin care companies such as Avon, Mary Kay, Revlon, etc. to market avVaa products under their specific brand name. This has already been done with VP Plus Marketing and Petonic Pet Supply. NEUROSKIN is registered as FDA compliant, both as a skin care cosmetic and over-the-counter pharmaceutical product, the market appeal for private branding and cosmetic companies is very strong.




 

 

SureTrader
Interactive Brokers Advertisement
AVVH
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#10901   Let's go AVVH $$$$$$$ ed7777777 10/26/17 11:48:01 PM
#10900   Some volume today! ed7777777 10/24/17 08:16:22 PM
#10899   No, didn't know anything about AVVAA World Health ed7777777 06/21/17 02:40:45 AM
#10898   Float was reported @ 1,882,828,559 on 7/29/2013. Canadians stocksmanjr 06/20/17 09:50:30 PM
#10897   A good portion of the shares bought today stocksmanjr 06/20/17 09:32:29 PM
#10896   Did she say anything about a connection to stocksmanjr 06/20/17 09:09:18 PM
#10895   This is what I could find AVVAA World ed7777777 06/20/17 04:46:57 PM
#10894   AVVAA World Health Care Products, Inc. is a ed7777777 06/20/17 04:35:53 PM
#10893   Lets roll AVVH I have been sitting on ed7777777 06/20/17 04:31:05 PM
#10892   Someone bought $15000 worth of AVVH on May stocksmanjr 06/20/17 12:02:01 AM
#10891   Another $1000 worth bought today... stocksmanjr 06/08/17 09:05:32 PM
#10890   16 million bought @ 0003($4800) between May 19 stocksmanjr 06/06/17 10:48:32 AM
#10889   Up 1 tick on 20000 volume? ed7777777 05/28/17 11:36:33 AM
#10888   Just checked this after months... seems like some frodo66 05/23/17 09:21:40 AM
#10887   L2 looks clean -- see post 10877 stocksmanjr 05/22/17 09:43:13 PM
#10886   Anybody out there with level 2 can you mccarl 05/22/17 03:02:11 PM
#10885   AVVH lets get it on! $$$$$$$ ed7777777 05/21/17 03:38:59 PM
#10884   Yeh, and 50 million a day volume is EnggMind 05/19/17 07:10:16 PM
#10883   Float is likely less than 400 million (unrestricted stocksmanjr 05/19/17 06:49:24 PM
#10882   The available float is tiny. Previous owners own stocksmanjr 05/19/17 06:48:02 PM
#10881   Something must be in the works why else stocksmanjr 05/19/17 06:39:44 PM
#10880   BOOM! 3s on deck and looking thin! BennySlots 05/19/17 02:13:30 PM
#10879   AVVH .0003 $treet Trader 05/19/17 02:11:10 PM
#10878   $AVVH .0003 will never last . When MONSTA MONSTAMONEYMOVA 05/19/17 02:01:20 PM
#10877   Yeah, L2 looks really clean. For minute there, BennySlots 05/19/17 01:50:54 PM
#10876   $AVVH any good DD on this ? LEVEL MONSTAMONEYMOVA 05/19/17 01:32:16 PM
#10875   Haven't seen this volume for years now. What EnggMind 05/19/17 01:31:06 PM
#10874   $AVVH looks ready MONSTAMONEYMOVA 05/19/17 01:26:23 PM
#10873   MONSTA MONSTAMONEYMOVA 05/19/17 01:25:51 PM
#10872   Big volume today. Anyone know what's going on here? BennySlots 05/19/17 01:24:03 PM
#10871   What is DTC? AVVH was current in the stocksmanjr 04/11/17 07:15:50 PM
#10870   Is AVVH DTC eligible? Bayutiger 04/11/17 12:06:16 AM
#10869   Is AVVH DTC eligible? Bayutiger 04/11/17 12:05:50 AM
#10868   Is AVVH DTC eligible? Bayutiger 04/11/17 12:05:48 AM
#10867   Can someone with L2 give some details? stocksmanjr 03/27/17 03:27:49 PM
#10866   Perhaps some news will be coming. AVVH still stocksmanjr 03/27/17 03:25:35 PM
#10865   Another 2 mil @ 0002. The available float stocksmanjr 03/27/17 03:21:20 PM
#10864   Trip 3 up. Initial alert was .0001 via twitter pennystockingz 03/21/17 11:39:28 AM
#10863   0003 on ask!!! 0002 taken out with stocksmanjr 03/21/17 10:14:41 AM
#10862   Nice work!!! mccarl 03/20/17 10:51:27 PM
#10861   A/S : 4,000,000,000 O/S: 1,882,828,559 7/29/2013 stocksmanjr 03/20/17 04:57:54 PM
#10860   AVVH jumps to 0002 on 488k share trade!! stocksmanjr 03/20/17 04:48:09 PM
#10859   Canada is still in chill mode and can't stocksmanjr 03/20/17 11:06:51 AM
#10858   Been waiting a long time,very interesting.Any idea how mccarl 03/15/17 11:42:13 PM
#10857   Seems to be some interest. someone has been stocksmanjr 03/15/17 11:10:38 PM
#10856   It's alive ?....... mccarl 03/14/17 04:37:25 PM
#10855   Available float is small due to shareholders in stocksmanjr 02/27/17 01:45:00 PM
#10854   Petonic pet supplies still selling in Canada: stocksmanjr 02/27/17 01:42:14 PM
#10853   This will move up on little volume. There stocksmanjr 02/27/17 01:32:24 PM
#10852   Vol .0002 up pennystockingz 02/27/17 11:03:41 AM
PostSubject